| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8921820 | Frontiers in Laboratory Medicine | 2017 | 6 Pages |
Abstract
Mechanisms of colistin resistance in clinical strains of A. baumannii show that colistin may not serve as an antibiotic of the last resort for treating MDR A. baumannii infections when other antibiotics are ineffective. The mechanisms of colistin resistance should provide an impetus for future research on the development of newer alternative therapies to treat emerging MDR A. baumannii.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Wenli Zhang, Bhowmik Aurosree, Bhavani Gopalakrishnan, Joan-Miquel Balada-Llasat, Vijay Pancholi, Preeti Pancholi,